Descripción del proyecto
Personal Health Systems for Monitoring and Point-of-Care diagnostics
TheraEDGE is an industry-driven effort to accelerate the adoption of theranostics applications in Primary Care by pushing Point of Care Test (POCT) technology far beyond its current state-of-the-art and by delivering clinical, analytical and operational breakthroughs.TheraEDGE is built around the high-incidence clinical case of early-diagnosing lower respiratory tract infections in Primary Care. Simultaneous testing for different pathogens and their antibiotic resistance will have a huge European impact:better clinical outcomes and standards of care through more effective and timely diagnosis and treatmentimproved health economics through optimization of antibiotics prescription, infection control practices and reduction of clinical visits or hospital stayssubstantial business for the In Vitro Diagnostics industry through the standardisation and commercialization of innovative POCT products and systemsTheraEDGE consists of three multidisciplinary platforms:a core Lab-On-a-Chip supporting multi-marker assays and using Single Molecule Detection (SMD) as an alternative to PCR-based molecular diagnostics. SMD removes the need for amplification and has the potential to become a key enabler for Nucleic Acid Testing at the Point of Care by providing less complex, faster, more sensitive and more specific assaysan architecture that provides Plug and Play semantic interoperability and creates opportunities for the standardisation of POCT instruments and information systems, offering radical usability, robustness and vendor interoperability improvements. Practitioners will be able to run out-of-the-box multiple compliant devices from one single PDA-based operator interfacea set of applications built on a convergent ITC platform that supports General Practitioners in their patient management and clinical decision-making, and provides therapeutic services for patient education and compliance monitoring in order to fight antibiotic misuse and abuse.
Ámbito científico
- natural sciencesbiological sciencesbiochemistrybiomoleculesnucleic acids
- engineering and technologyother engineering and technologiesmicrotechnologylab on a chip
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsantibiotics
- social scienceseconomics and businesseconomicshealth economics
- medical and health sciencesbasic medicinepharmacology and pharmacydrug resistanceantibiotic resistance
Convocatoria de propuestas
FP7-ICT-2007-1
Consulte otros proyectos de esta convocatoria
Régimen de financiación
CP - Collaborative project (generic)Coordinador
08186 LLIÇA D´AMUNT
España
Ver en el mapa
Participantes (15)
2000 Antwerpen
Ver en el mapa
33615 Bielefeld
Ver en el mapa
01069 Dresden
Ver en el mapa
55129 Mainz
Ver en el mapa
08036 BARCELONA
Ver en el mapa
08007 Barcelona
Ver en el mapa
08186 LLICA D'AMUNT
Ver en el mapa
08186 LLICA D´AMUNT
Ver en el mapa
10123 TORINO
Ver en el mapa
7522 NB Enschede
Ver en el mapa
2500-750 Caldas Da Rainha
Ver en el mapa
581 83 Linköping
Ver en el mapa
81339 BRATISLAVA
Ver en el mapa
CB2 1TN Cambridge
Ver en el mapa
TF9 4PA Shropshire
Ver en el mapa